IL6R and thyroid gland carcinoma: It should also be noticed that IL1RA is an acute phase marker and high levels have previously been associated with aggressive disease and/or adverse prognosis in various malignancies, including T cell lymphoma [82], sarcoma [83], colorectal cancer [84,85], and thyroid cancer [86].